A multicultural group practicing yoga together in a bright studio

Direct Meds vs telos rx: GLP-1 Comparison 2026

Direct Meds vs telos rx: pricing, medication type, clinical support, and which mid-market GLP-1 patient each program fits. Both programs’ prices verified July 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated July 25, 20264 min read

Quick answer

Direct Meds and telos rx both offer GLP-1 telehealth, but they package medication, support, and pricing differently. The right choice depends on whether you weight cost, clinical touch, or formulation flexibility highest.

Side-by-side comparison

Feature	Direct Meds	telos rx
Best for	Multiple compounded formats (injection and sublingual)	One integrated care team across GLP-1, hormones/longevity, sexual health, and recovery (peptide-led telehealth) rather than a single-indication weight-loss pure-play
Medication type	Compounded semaglutide and tirzepatide	Compounded semaglutide and tirzepatide (injectable, plus needle-free oral/sublingual and a microdosed tirzepatide) inside an integrated peptide-led telehealth menu; medical services by an independent US-licensed medical group (Arora Health Group)
Pricing model	All-inclusive monthly price by medication format	Cash-pay subscription with 'first month low as' intro pricing per medication; the ongoing recurring rate is NOT published on the public site (funnel-gated at start.telosrx.com), no single defensible recurring price (Oak/LIV Body mechanism)
Semaglutide price	From $249/mo (sublingual) to $297/mo (injection), all-inclusive, verified 2026-07-25 on Direct Meds' own product pages ('$249.00 / month … Billed Every Month', '0% OFF')	Compounded, advertised 'first month low as $49'; ongoing recurring rate not published (funnel-gated), confirm at enrollment
Tirzepatide price	From $299/mo (sublingual) to $399/mo (injection), all-inclusive, verified 2026-07-25	Compounded, injectable advertised 'first month low as $99'; oral 'first month low as $49'; microdosed 'first month low as $69'; ongoing recurring rate not published, confirm at enrollment
Key watchout	Pricing varies by format and page, product-page 'all-inclusive' rates differ from homepage promo cards; confirm your format's rate at checkout	telos publishes only 'first month low as' intro figures (semaglutide $49, tirzepatide $99, oral tirzepatide $49, microdosed tirzepatide $69); the ongoing monthly rate is not shown on the public site and is confirmed inside the intake flow, confirm the real recurring price at enrollment. State availability is not published, no dispensing pharmacy is named, and shipped compounded medication is non-refundable.
Price checked	Checked by a person July 25, 2026	Checked by a person July 17, 2026

When to choose Direct Meds

You want a specific format, injection or sublingual, at a clear all-inclusive price
You're already familiar with GLP-1 dosing and side-effect management
You don't need a coach or a heavy-touch clinical team
You want a no-frills, predictable monthly bill

Check current Direct Meds pricing →

When to choose telos rx

You want one integrated care team across GLP-1 weight loss, longevity/energy (NAD+), recovery (sermorelin), and sexual health (PT-141) rather than a single-indication program
You value an upfront 'compounded / not FDA-approved' disclosure and a LegitScript-certified telehealth platform
You're comfortable confirming the real ongoing monthly price at enrollment (telos publishes only 'first month low as' intro figures)
You want async care with a 5-minute online visit and a 100% refund if a clinician decides a GLP-1 isn't the right fit

Check current telos rx pricing →

Full reviews

Frequently asked questions

Is Direct Meds cheaper than telos rx?

Neither Direct Meds nor telos rx is uniformly cheaper, both publish dose-banded and formulation-banded pricing that depends on the exact product, dose, and any insurance pathway. Compare the specific tier you'd be on at each before deciding.

Which is better for semaglutide or tirzepatide, Direct Meds or telos rx?

Both Direct Meds and telos rx prescribe semaglutide and tirzepatide where appropriate. Choose based on how each program handles your target medication, not just the entry price.

Are Direct Meds and telos rx compounded or brand-name?

Direct Meds offers compounded semaglutide and tirzepatide. telos rx offers compounded semaglutide and tirzepatide (injectable, plus needle-free oral/sublingual and a microdosed tirzepatide) inside an integrated peptide-led telehealth menu; medical services by an independent us-licensed medical group (arora health group). If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Direct Meds to telos rx?

Yes, switching between Direct Meds and telos rx is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Direct Meds and telos rx to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like $249/mo (sublingual) to $297/mo (injection), all-inclusive, verified 2026-07-25 on Direct Meds' own product pages ('$249.00 / month … Billed Every Month', '0% OFF') and Compounded, advertised 'first month low as $49'; ongoing recurring rate not published (funnel-gated), confirm at enrollment are starting tiers, not your guaranteed long-term cost.